Yifeng Pharmacy (603939) — Capital Reinvestment Ratio
Yifeng Pharmacy (603939) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥641.93 Million) in capital expenditures (CN¥44.81 Million). See Yifeng Pharmacy (603939) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yifeng Pharmacy Capital Reinvestment Ratio (2011–2024)
This chart tracks Yifeng Pharmacy's Capital Reinvestment Ratio across 14 annual periods. Check cash flow reinvestment rate of Yifeng Pharmacy to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Yifeng Pharmacy (2011–2024)
Year-by-year Capital Reinvestment Ratio for Yifeng Pharmacy from 2011 to 2024. For live market cap and broader valuation context, see 603939 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | CN¥4.22 Billion | CN¥682.67 Million | ▲ +1.9% |
| 2023 | 0.16x | CN¥4.66 Billion | CN¥739.92 Million | ▲ +5.9% |
| 2022 | 0.15x | CN¥3.92 Billion | CN¥587.51 Million | ▼ -61.1% |
| 2021 | 0.38x | CN¥2.15 Billion | CN¥827.54 Million | ▼ -11.8% |
| 2020 | 0.44x | CN¥1.34 Billion | CN¥582.80 Million | ▼ -7.4% |
| 2019 | 0.47x | CN¥963.23 Million | CN¥454.05 Million | ▲ +3.0% |
| 2018 | 0.46x | CN¥510.71 Million | CN¥233.67 Million | ▼ -29.8% |
| 2017 | 0.65x | CN¥317.20 Million | CN¥206.73 Million | ▼ -64.2% |
| 2016 | 1.82x | CN¥139.94 Million | CN¥254.86 Million | ▲ +103.6% |
| 2015 | 0.89x | CN¥181.52 Million | CN¥162.37 Million | ▲ +97.9% |
| 2014 | 0.45x | CN¥212.35 Million | CN¥95.98 Million | ▲ +25.1% |
| 2013 | 0.36x | CN¥156.71 Million | CN¥56.61 Million | ▼ -68.4% |
| 2012 | 1.14x | CN¥80.73 Million | CN¥92.21 Million | ▲ +46.2% |
| 2011 | 0.78x | CN¥122.99 Million | CN¥96.09 Million | — |